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Abstract 27 
Cyanobacteria are the predominant phototrophs in freshwater ecosystems of the polar regions 28 
where they commonly form extensive benthic mats. Despite their major biological role in these 29 
ecosystems, little attention has been paid to their physiology and biochemistry. An important feature 30 
of cyanobacteria from the temperate and tropical regions is the production of a large variety of toxic 31 
secondary metabolites. In Antarctica, and more recently in the Arctic, the cyanobacterial toxins 32 
microcystin and nodularin (Antarctic only) have been detected in freshwater microbial mats. To date 33 
other cyanobacterial toxins have not been reported from these locations. Five Arctic cyanobacterial 34 
communities were screened for saxitoxin, another common cyanobacterial toxin, and microcystins 35 
using immunological, spectroscopic and molecular methods. Saxitoxin was detected for the first time 36 
in cyanobacteria from the Arctic. In addition, an unusual microcystin variant was identified using 37 
liquid chromatography–mass spectrometry. Gene expression analyses confirmed the analytical 38 
findings, whereby parts of the sxt and mcy operon involved in saxitoxin and microcystin synthesis, 39 
were detected and sequenced in one and five of the Arctic cyanobacterial samples, respectively. The 40 
detection of these compounds in the cryosphere improves the understanding of the biogeography 41 
and distribution of toxic cyanobacteria globally. The sequences of sxt and mcy genes provided from 42 
this habitat for the first time may help to clarify the evolutionary origin of toxin production in 43 
cyanobacteria.  44 
 45 
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1. Introduction 49 
Few phototrophic organisms survive the harsh climate of the high Arctic regions. This includes some 50 
higher plants, mosses, lichens, various algal groups and cyanobacteria. Cyanobacteria are globally 51 
distributed, but in high Arctic freshwater ecosystems they represent the dominant primary producers 52 
[1,2]. Special features such as resistance to ultraviolet (UV) radiation, freeze-thaw cycle adaptation 53 
and nitrogen fixation allow their survival in these extreme environments [2]. During the polar 54 
summer, when both light and temperatures above the freezing point prevail, cyanobacterial 55 
communities thrive. They develop highly diverse benthic or floating mats in freshwater streams and 56 
ponds that can be several centimeters thick and extend over large areas [2,3]. These extensive mats 57 
form the basis of a small but diverse and dynamic ecosystem accommodating a variety of organisms 58 
such as nematodes, rotifers, tardigrades [4], mosses and moss-infecting oomycetes such as the 59 
recently-described Pythium polare [5]. 60 
 61 
Saxitoxins (STXs) (Figure 1A) are carbamate alkaloids, a group of fast-acting neurotoxins, inhibiting 62 
neuronal signal propagation of most higher organisms [6]. They are typically produced by marine 63 
dinoflagellates [7].However, planktonic and benthic cyanobacteria from temperate and tropical 64 
regions, e.g. Aphanizomenon spp., Anabaena circinalis, Cylindrospermopsis raciborski, Planktothrix 65 
spp., and Lyngbya wollei [8], are also known to produce STXs. Microcystins (MCs) (Figure 1B)  on the 66 
other hand, represent a group of ≥80 structural heptapeptide variants with varying hepato-, renal-, 67 
and neurotoxicity [9,10]. They appear to act primarily via specific inhibition of serine/threonine 68 
phosphatases [8,10], thereby interfering with one of the most important regulatory mechanisms of 69 
the cell. MCs are produced by a large variety of planktonic and benthic cyanobacterial genera 70 
including Microcystis, Nostoc, Planktothrix, Anabaena, Synechococcus and Snowella [8,11].  71 
 72 
The molecular basis for the production of both toxins are large and variable gene clusters, encoding 73 
enzymes involved in secondary metabolite production such as polyketide synthetases and/or non-74 
ribosomal peptide synthetases [12–14]. The distribution of this gene cluster among different strains 75 
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of cyanobacteria does not necessarily correlate with the actual production of the toxins  [15]. 76 
Therefore the presence of these genes in a given ecosystem is only an indication for the presence of 77 
the toxins and is therefore considered in this study as providing evidence for the ‘potential to 78 
produce toxins’. These biosynthetic steps are energetically expensive for cyanobacteria  [16], and this 79 
has  prompted considerable speculation on their ecological function. To date the  physiological 80 
function and ecological regulation of both STXs and MCs are poorly understood [17–19]. The current  81 
hypotheses aiming to explain this relatively enormous investment of energy in the synthesis of these 82 
toxins, include protection against grazing pressure, UV-radiation, and reactive oxygen species, as well 83 
as their function as signaling molecules in a quorum sensing-like manner [16,19–22]. The 84 
development of toxins as protection against grazers appears to be the least plausible hypothesis as 85 
the corresponding gene clusters appear to have been present in ancestral cyanobacteria species that 86 
have existed prior to the mesoproterozoic period [23–25], i.e. millions of years prior to the 87 
emergence of potential eukaryotic grazers of cyanobacteria. However it can not be excluded that 88 
new functions have developed in the course of evolution. 89 
In view of the ancient origin and the high conservation of the toxin gene clusters it is not surprising 90 
that cyanobacteria inhabiting remote pristine areas, e.g. the rudimentary environments of the polar 91 
regions, could produce toxins. The presence of MCs in cyanobacterial mats has been reported for 92 
several locations in Antarctica [26–28], whereas this has only recently been demonstrated for Arctic 93 
cyanobacteria from northern Baffin Island [29]. Kleinteich et al. (2012) [29] demonstrated that 94 
culturing of cyanobacterial mats in the laboratory at increased temperatures caused a marked rise in 95 
the concentration of MCs in concert with shifts in the diversity of the cyanobacterial mat community 96 
composition. Saxitoxins, on the other hand, have never been reported in polar environments and 97 
cyanobacterial toxins in general remain understudied in this habitat.  98 
 99 
In this study five cyanobacterial communities from the Arctic were screened for the presence of STX 100 
using enzyme-linked immunosorbent assay (ELISA) and further confirmation was undertaken using 101 
high performance liquid chromatography with fluorometric detection (HPLC-FLD). Furthermore an 102 
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unusual MC variant was identified using liquid chromatography-mass spectrometry (LC-MS).  103 
Samples were also screened for selected genes involved in the synthesis of MC and STX, thereby 104 
providing evidence of the toxin-producing potential of Arctic cyanobacterial communities. 105 
 106 
2. Materials and Methods 107 
2.1 Study sites and sampling 108 
Five samples of cyanobacterial communities were collected during an expedition to northern Baff in 109 
Island in the vicinity of Cape Hatt (72°30’ N and 79°47’ W) in August to September 2009 from 110 
microbial communities on wet soil, small streams and ponds (see Supplemental Figure 1 for GPS 111 
coordinates). Samples for DNA extraction and toxin analysis were sealed in sterile tubes, those for 112 
RNA analysis stored in RNAlater (Qiagen, Hilden, DEU) and frozen ( -20 °C) until further analysis. 113 
 114 
2.2 Screening for saxitoxin and microcystin 115 
2.2.1 Saxitoxin extraction 116 
Frozen cyanobacterial material was lyophilized and their dry weight recorded. Sample for STX 117 
analysis were extracted as described by Smith et al. (2011) [30]. Briefly, 50 mg of lyophilized material 118 
was homogenized in 5 mL H2O using a mortar and pestle and dried under nitrogen flow. The dried 119 
material was dissolved methanol (4 mL) acidified with acetic acid (0.1 %), vortexed (15 min), and 120 
placed in an ultrasonic water bath (15 min, ice cold). The suspension was centrifuged (30 min, 4,000 x 121 
g) and the supernatant transferred into a separate tube for HPLC-FLD analysis. 122 
 123 
To ensure complete STX recovery from the residual pellet, 5 mL HCl (0.1 M) was added and the pellet 124 
boiled (5 min, 100 °C), directly followed by ultra-sonication (10 min, ice cold). Cell debris was 125 
removed by centrifugation (30 min, 3,000 x g), and the supernatant adjusted to pH 7.0 with NaOH. 126 
The supernatant was filtered through a 0.2 µm filter and pooled with the supernatant obtained in the 127 
first extraction. The pooled supernatant was dried under nitrogen gas flow and stored at -20 °C until 128 
HPLC-FLD analysis.  129 
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 130 
2.2.2 Microcystin extraction 131 
Lyophilized material (173 mg) was homogenized to a powder using a mortar and pestle Methanol 132 
(75 %, 5 mL) was added to the powder, the suspension placed in an ultrasonic water bath for 30 min 133 
(ice-cold), centrifuged (30 min, 4,000 x g), and the supernatant removed for further processing. The 134 
extraction was repeated three times. The supernatants were pooled, dried under nitrogen flow, re -135 
suspended in 15 mL H2O, and loaded onto C18 cartridges (Sep-Pak, Waters, Dublin, IRL). MC was 136 
eluted from the C18 cartridges with methanol (100 %), the methanolic eluate dried under nitrogen 137 
gas flow, and resuspended in 3 mL methanol (20 %). The extract was centrifuged (20 min, 13,000 x g) 138 
and the supernatant stored at -20 °C until further analyses. 139 
 140 
2.2.3 Saxitoxin analysis  141 
The STX (PSP) ELISA kit (ABRAXIS, Warminster, USA) was employed to analyze for STX according to 142 
the manufacturer’s protocol. This STX (PSP) ELISA has a limit of detection (LOD) of 0.0215 ng / mL. 143 
Analytical data were generated based on three independent replicate analyses each with duplicate 144 
technical replicates.  145 
Saxitoxins were also analyzed using HPLC-FLD as described Smith et al. (2011) [30]. This HPLC 146 
detection method had a LOD of 0.1 mg / kg total STXs. 147 
 148 
2.2.4 Microcystin analysis 149 
The extract of cyanobacterial sample A , which had previously tested positive for MC by A DDA-ELISA 150 
[29], was analyzed by LC-MS in order to identify the MC congener/s present. LC-MS was undertaken 151 
on a HPLC system (UltiMate 3000; Dionex) coupled to an AmaZon X (Bruker Daltonics) electrospray 152 
ionization-ion trap mass spectrometer (ESI-IT-MSn). Samples (20 µL) were separated on a C18 column 153 
(Ascentis Express C18, 100 × 2.1 mm, 2.7-µ; Supleco Analytical) using a gradient system of 98 % H20 + 154 
0.1 % formic acid (v/v; solvent A) and 98 % acetonitrile + 0.1 % formic acid (v/v; solvent B) with the 155 
following gradient program; the sample was loaded in 10 % B; 10 % B was held for 1 min and 156 
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increased to 100 % B over 12 min; 100 % B was held for 2 min; the solvent concentration was 157 
returned to 10 % B in 1 min and the column re-equilibrated for 4 min. The eluting compounds were 158 
transferred into the IT-MS using a capillary voltage of 3.5 kV and a nebulizer pressure of 3.0 bar. 159 
Desolvation was accomplished with a nitrogen flow of 8 L / min at 220 °C. Tandem MS (MS/MS) 160 
spectra were gathered using the doubly- or singly-protonated ions of the target compounds and 161 
collision-induced dissociation (CID) to induce fragmentation of the parent ion (collision amplitude of 162 
1.0). 163 
 164 
2.3 Screening for genes involved in toxin synthesis 165 
2.3.1 Nucleic acid extraction 166 
DNA was extracted from 5 - 10 mg of frozen material using the MO BIO PowerSoil® DNA Isolation Kit 167 
following the manufacturer’s recommendations. Due to the heterogeneity of the sample material, 168 
three individual extractions were performed and the pooled extracts used for downstream 169 
applications. RNA was extracted from 5 - 10 mg of material stored in RNAlater (Qiagen, Hilden, DEU). 170 
RNAlater was removed by patting the material on a dry stack of paper, and RNA extracted using the 171 
MO BIO PowerBiofilm® RNA extraction kit following the manufacture’s protocol. RNA was eluted 172 
with RNase-free water and stored at -80 °C.  173 
 174 
2.3.2 Detection of genes involved in toxin synthesis 175 
PCRs targeting the mcy and sxt operon for MC and STX synthesis respectively were performed with 176 
primer pairs and at annealing temperatures as listed in Supplemental Table 2; primers were from 177 
MWG eurofins (Ebersberg, DEU). For the reactions either the Master Mix™ (Fermentas, St. Leon -Rot, 178 
DEU) or the Phusion™ polymerase mix (NEB, Ipswich, USA) was used supplemented with BSA, DMSO 179 
and MgCl2. Bands were excised from a 1.5 % agarose gel (TAE) using a sterile scalpel, purified with a 180 
gel extraction kit (Fermentas, St. Leon-Rot, DEU) and sequenced bi-directionally using the primers 181 
listed in Supplemental Table 1 at MWG eurofins (Ebersberg, DEU). Messenger-RNA of the sxt operon 182 
was reverse transcribed into cDNA using gene-specific reverse primers (Supplemental Table 2) and a 183 
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standard protocol for reverse transcription (20 U RNAse Inhibitor, 0.8 mM dNTPs, 7 µL of extracted 184 
RNA, 70 U M-MuLV). Enzyme and chemicals for RT-PCR were from NEB (Ipswich MA, USA). The cDNA 185 
produced was used as template for PCR as described above. Microcystis aeruginosa CCAP 1450/16 186 
served as a positive control for mcy genes, but no positive control of cyanobacterial origin was 187 
available for the sxt genes. The obtained sequences were analyzed using Geneious™ software 188 
(Geneious Pro 5.3.6) and the closest matches identified using NCBI’s BLAST tools (mega-BLAST and 189 
BLASTn). Phylogenetic trees using sxtA sequences were built using the GeneiousTM tree builder 190 
(Jukes-Cantor, Neighbour joining method). The obtained 657 bp product of the sxtA gene was 191 
deposited in the GenBank database under the accession JX887897 (Supplemental Table 3). The 192 
obtained 128 bp product of the sxtA gene is displayed in Supplemental Table 5 since GenBank does 193 
not allow deposition of sequences shorter than 200 bp. 194 
 195 
2.4 Identification of toxin producer/s 196 
2.4.1 Cloning of 16S rRNA and intergenic spacer region (ITS)  197 
Two samples that returned positive results from toxin analyses were selected for construction of 16S 198 
rRNA gene and intergenic spacer region (ITS) region clone libraries. Amplification was achieved with 199 
the cyanobacteria-specific primer pair 27F and 23S30R (Supplemental Table 2) in a 50 µL PCR 200 
reaction (4 min, 95 °C; 35 x [92 °C, 60 s; 55 °C, 60 s; 72 °C, 120 s]; 72 °C, 10 min) containing the 201 
Fermentas (St. Leon-Rot, DEU) Master Mix, 2.5 mM MgCl2, 0.2 µg / µL BSA, 3 % DMSO and 0.5 µM of 202 
each primer. The PCR products were separated on a TAE 1.5 % agarose gel and the bands excised  203 
using a sterile scalpel. After purification with the GeneJET™ Gel Extraction Kit (Fermentas, St. Leon -204 
Rot, DEU) PCR products were cloned using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, USA) 205 
following the standard protocol with a DNA to vector ratio of four to one. For each sample 206 
approximately 40 clones were retrieved and conserved in sterile TE buffer. Each clone insert was 207 
amplified in a PCR reaction (95 °C, 4 min; 35 x [92 °C, 30 s; 52 °C, 30 s; 72 °C ,70 s]; 72 °C, 5 min) using 208 
the Fermentas PCR Master Mix (St. Leon-Rot, DEU), 0.25 µM of each TOPO-primer M13, 2 mM MgCl2, 209 
3 % DMSO and 0.3 µL of DNA template. Products were subjected to a Restriction Fragment Length 210 
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Polymorphism (RFLP) analysis using restriction enzymes AluI and ScrF1 (NEB, Ipswich, USA) (37 °C, 2 211 
h) and subsequently visualized on an agarose gel (TAE, 2.5 % agarose) in order to identify groups of 212 
multiple clones of the same phylotype. Two to three representative clones of each individual RFLP 213 
pattern (phylotype) were selected and sequenced at GATC Biotech, Konstanz, Germany using the 214 
TOPO-primers T3 and T7 as well as the 16S-rRNA gene-specific primers 27F, 359F and 23S30R for 215 
verification. The resulting sequences were analyzed using Geneious™ software (Geneious Pro 5.3.6) 216 
and their closest matches identified via a Mega-BLAST search of the GenBank database. Sequences 217 
were deposited in GenBank under the accession numbers as indicated in Supplemental Table 3. 218 
 219 
2.4.1 Morphological identification 220 
Microscopic analysis was performed using a Nikon Eclipse TS 100 Microscope and images 221 
documented with a Nikon Digital Sight DS-5M camera. Image quality was improved using XnView for 222 
Windows Software (version 1.97.6; Libformat version 5.70) and scale bars included by Corel Photo 223 
Paint 11 for Windows (version 11.633). Species identification down to genera level was made using 224 
the taxonomic guides of Komarek and Anagnostidis [31,32].  225 
 226 
2.5 Data evaluation 227 
Data were evaluated using Graphpad Prism™ Software (Prism 5 for Windows, Version 5.04).  228 
229 
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 230 
3. Results 231 
3.1 Detection of toxins in Arctic cyanobacterial communities 232 
3.1.1 Saxitoxin detection 233 
One of the five samples analyzed with the STX ELISA tested positive (Sample E; 21 (SD=16) µg STX / kg 234 
dry weight; n=6) well above the detection limit of the STX ELISA and in the centre of the standard 235 
curve. However the concurrent HPLC-FLD analyses were not able to confirm this finding, possibly due 236 
to the detection limit of the individual STX variants (LOD between 0.5 – 13 µg / kg). Additionally 237 
different sample matrices may result in matrix suppression which may increase limits of detection  238 
(Pers. comm. Michael Boundy, Cawthron, October 2012). None of the other samples tested positive 239 
in the STX ELISA, either as original samples or when cultured in the laboratory at various 240 
temperatures (see Kleinteich et al. (2012) [29] for laboratory culture conditions). Subsequent PCR 241 
amplification of two segments (128 bp and 657 bp) of the sxtA gene provided for a positive signal in 242 
sample E but not for the other four samples (Table 1). Additionally, the sxtA gene mRNA was 243 
detected in sample E (Figure 2). 244 
 245 
The sxtA gene encodes for a polyketide synthetase, which is part of the recently identified 246 
cyanobacterial sxt gene cluster [33]. The amplified 128 bp and 657 bp products of sample E were 247 
sequenced and compared to the GenBank data base. The 657 bp gene segment shared a high 248 
similarity with known sxtA genes from the freshwater cyanobacteria Scytonema cf. crispum (97 %, 249 
HM629429) and Lyngbya wollei (95 %, EU603711.1). In contrast, the 128 bp sequence was most 250 
similar to the sxtA gene of Aphanizomenon (99 %, HQ338481.1) and Anabaena circinalis (99 %, 251 
HQ338478.1) (Supplemental Table 3).  A phylogenetic tree (Figure 3) was constructed using the 657 252 
bp product of the sxtA gene in sample E, and the sequence grouped in the same clade as Lyngbya 253 
wollei (EU629174), and the Scytonema (HM629429) sequence. One Cylindrospermopsis (EU629178) 254 
and several Anabaena and Aphanizomenon sequences clustered in a different clade.  255 
 256 
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3.1.2 Microcystin detection 257 
Liquid chromatography-MS analysis of sample A (Figure 4A) that contained 106 µg MC / kg dry 258 
weight in the ELISA assay, showed that multiple MC variants were present in the extract. One of 259 
these compounds had a similar retention time to that of MC-RR (Figure 4B), but yielded a doubly-260 
protonated ion with m/z 526.7. Tandem MS of the m/z 526.7 ion revealed fragment ions resembling 261 
a di-arginated MC (minus CN2H2; [34]). Also observed in the fragment ions was a loss of 60 Da which 262 
suggested that the MC contained ADMADDA instead of the generally observed ADDA (minus HOAc;  263 
[35]). Assignment of the fragment ions indicated that this MC also contained alanine (Ala), arginine 264 
(Arg), aspartic acid (Asp), glutamic acid (Glu) and an 83 Da moiety (Mdha or Dhb) in the sequence 265 
Ala-Arg-Asp-Arg-ADMADDA-Glu-Mdha/Dhb (Table 2). This was most likely the known MC; [Asp3, 266 
ADMADDA5, Dhb7] MC-RR (Figure 5), previously described in Nostoc [36].  267 
 268 
There were several minor compounds present in Sample A that showed some structural similarity to 269 
MCs, but could not be identified using the current sample due to insufficient individual compound 270 
quantity. The four other samples which previously tested negative for MC by ELISA [29] tested 271 
negative for MC by LC-MS. 272 
 273 
All five samples were tested for the presence of genes of the mcy gene cluster, responsible for MC 274 
synthesis. Three different genes involved in MC synthesis (mcyA, mcyE and polyketide synthase 275 
regions) were amplified for sample A, which had tested positive for MC in the ELISA and LC-MS 276 
analysis, providing a product of the correct size (Table 1). Subsequent sequencing of the products 277 
and GenBank comparison however resulted in only one product annotated to a gene involved in 278 
secondary metabolite production, i.e. an amino acid adenylation domain of Clostridium 279 
(Supplemental Table 3). The other two products did not result in a specific identification of an 280 
annotated gene.  281 
 282 
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For the other four samples (B-E), negative for MC in the ELISA and LC-MS analysis, at least one gene 283 
involved in MC synthesis was amplified, sequenced and annotated in GenBank to a known gene 284 
involved in MC synthesis (Supplemental Table 3) with similarities ranging between 60 % and 99 %. In 285 
total, seven sequences, annotated to genes involved in MC synthesis, were amplified. The genera 286 
corresponding to these genes were Microcystis, Nostoc and Microcoleus (Supplemental Table 3). 287 
 288 
3.2 Potential toxin producers in Arctic cyanobacterial communities 289 
A clone library was constructed for the samples that contained either MC (sample A) or STX (sample 290 
E) to identify the potential toxin producers. Genera were also identified using light microscopy.  291 
Molecular characterization of the 16S-ITS region demonstrated that the species present in the STX 292 
containing sample E were most similar to: Nostoc puntiforme (CP001037, 95 %), Leptolyngbya 293 
(frigida) (AY493573, 97 %), Calothrix sp. (JN385289, 92 %), Snowella littoralis (AJ781040, 98 %), and 294 
Tolypothrix distorta (GQ287651, 98 %).  Fewer cyanobacterial signals were obtained for sample A, 295 
and the sequences were most similar to; Aphanizomenon gracile (FJ424575, 94 %), Leptolyngbya sp. 296 
(DQ431004, 94 %), and Chroococcus (FR798926, 97 %). Light microscopy showed that both samples 297 
had a similar appearance, with dominating Nostocales embedded in a firm mucilaginous matrix. 298 
Other orders, albeit in lower abundance, i.e. Oscillatoriales (e.g.  Leptolyngbya) and Chroococcales 299 
were also present. The Nostocales observed had cells of 3 – 6 µm in diameter and contained 300 
heterocytes (Supplemental Figure 2). Leptolyngbya with a trichome width of approximately 1.7 µm 301 
was present in both samples. In Sample A Tolypothrix was characterized by dark brown colored 302 
sheaths and a trichome width of approximately 15 µm. 303 
 304 
4. Discussion 305 
Cyanobacterial toxin production is a worldwide phenomenon with concomitant widespread adverse 306 
health effects in humans and wildlife of the temperate and tropical regions [37,38].  The adverse 307 
effects are not only of acute nature but can also entail fundamental changes to whole ecosystems 308 
upon chronic or intermittent acute exposure events [39,40]. Despite the high abundance of 309 
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cyanobacteria in the Arctic [2], at present there is only a single recent report of MCs in Arctic 310 
cyanobacteria [29] and in cyanobacteria associated lichen [41]. Although MC was below the limit of 311 
detection in most of the environmental samples analyzed by Kleinteich et al. (2012) [29], MC 312 
concentrations increased dramatically when cultured under laboratory conditions and at higher 313 
ambient temperatures. This was also associated with a profound change in the species diversity of 314 
the cyanobacterial mats investigated. Whether the higher toxin quantities produced and/or the 315 
higher temperatures induced the change in species diversity could not be determined. These data 316 
suggest that continued climatic change may led to increases in cyanotoxins in polar regions. In an 317 
extension this study, the same cyanobacterial communities from the Canadian Arctic were analyzed 318 
for the presence of STX and further characterization of the MC was undertaken.  319 
  320 
4.1 Saxitoxins in Arctic cyanobacteria and their potential producers 321 
The presence of STX was confirmed for the first time in a polar freshwater environment via 322 
immunological analyses as well as the detection of part of the sxt gene cluster and the corresponding 323 
mRNA product. The levels detected (21 µg STX / kg dry weight) were much lower than those reported 324 
for pure cultures of benthic cyanobacteria of temperate regions (Scytonema cf. crispum, 66 x 106 µg 325 
STX / kg dry weight [30]; Lyngbya wollei, maximum 58 x 106 µg STX / kg dry weight [42]). The latter 326 
difference is likely a result of the low abundance of the producer in a mixed environmental sample 327 
and low nutrient availability in contrast to a pure culture. Lack of STX detection using HPLC-FLD may 328 
be explained by the fact that approximately 26 different variants of STXs are known to date [43]. 329 
HPLC analysis relies on the detection of each individual STX variant. In contrast, multiple STX variants 330 
can be detected with the ELISA, albeit with different affinities according to the manufacturer (e.g. 331 
decarbamoyl STX with 29% and GTX 2 & 3 with 23%), thus giving a sum value of STXs present in the 332 
respective sample analyzed. Thus if multiple variants are present in a sample, reliable HPLC detection 333 
depends upon the concentration level of each variant present and not on the total STX concentration 334 
(as determined by STX-ELISA).   335 
 336 
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In contrast to MC which is widely distributed among cyanobacterial taxonomic groups [12], only a 337 
few cyanobacterial species have been reported to produce the STXs, including Aphanizomenon, 338 
Planktothrix, Scytonema and Lyngbya [30]. The limited number of STX producing cyanobacteria may 339 
explain why STXs and the sxt genes were detected only in one out of five Arctic cyanobacterial 340 
samples analyzed. Consequently, the distribution of STX producing species in the Arctic, at least in 341 
the area studied, could be limited and solely dependent on the unique species composition of the 342 
respective cyanobacterial community. Although the STX producing species could not be identified, 343 
Scytonema or Lyngbya appeared likely candidates. The latter genus seems to have a widespread 344 
distribution in the Arctic regions as it has been reported from the Canadian High Arctic [44,45], as 345 
well as Spitsbergen [46]. The sxtA sequence obtained from this sample showed highest sequence 346 
similarity to Lyngbya and Scytonema sequences. Tolypotrix or Scytonema were identified in the 347 
sample by microscopy and Tolypothrix had the closest match in the 16S rRNA gene sequence library. 348 
Tolypothrix and Scytonema both belong to the order of Nostocales and  Scytonema has recently been 349 
identified as a STX producer [30]. 350 
 351 
4.2 Microcystins in Arctic cyanobacterial communities and their potential producers 352 
In a previous study MC was detected in one of the five cyanobacterial samples (Sample A) using an 353 
ADDA specific ELISA assay [29]. In the present study the MC congener in Sample A was putatively 354 
identified as [Asp3, ADMADDA5, Dhb7] MC-RR. Although there are no studies available on the cross-355 
reactivity of ADMADDA with the ADDA specific antibody of the ADDA-ELISA kit, it is possible that the 356 
concentration of the ADMADDA substituted MC variant is underestimated in this assay. The [Asp3, 357 
ADMADDA5, Dhb7] MC-RR  variant has been reported before by Beattie et al. (1998) [36] in a Nostoc 358 
strain (DUN901) isolated from brackish water in the United Kingdom and is reported here for the first 359 
time in the Arctic region. A MC with the same mass, [Asp3, ADMADDA5] MC-RR, was recently 360 
reported in lichen (Peltigrea membranacea / Peltigrea hymenia) associated cyanobacteria (most 361 
likely Nostoc or Nodularia) from Scotland [41]. While Kaasalainen et al. (2012) reported the presence 362 
of [Asp3, ADMADDA5] MC-RR, the characterization of the MC congeners identified was not reported. 363 
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As MS/MS alone cannot discriminate between Mdha and Dhb, it is possible that the MC identified in 364 
their study could have also contained a Dhb moiety.  365 
 366 
MCs have been reported previously in a range of habitats in continental Antarctic (McMurdo Ice 367 
Shelf, Bratina Island and Dry Valleys; [26–28]). The MC analyses demonstrated the presence of new 368 
and unusual MC congeners, e.g. [Gly1] MC-LR and -RR, some of which contained the acetyldesmethyl 369 
ADDA [ADMADDA5] substitution [27] also observed in this study. Wood et al. (2008) identified the 370 
cyanobacterial genus Nostoc as an Antarctic MC producer [27] based on microscopy and molecular 371 
methods. The latter corroborated the reports by Beattie et al. (1998) and Kaasalainen et al. (2012) 372 
[36,41] suggesting that Nostoc could be the producer of the [Asp3, ADMADDA5, Dhb7] MC-RR 373 
congener. Even though in this study all of the Arctic cyanobacterial communities were dominated by 374 
Nostocales, other potential MC producing genera of cyanobacteria were observed, e.g. Leptolyngbya 375 
[48]. Both Nostoc and Leptolyngbya were detected via genetic and microscopic analyses in samples A 376 
and E. Due to the unusual MC congener identified and the information provided by earlier 377 
publications [36,41,47], it is hypothesized that Nostoc could also be the MC producer in this Arctic 378 
sample. However, an exact identification of the MC producer is not possible based on the currently 379 
available data and attempts at sub-culturing the producer remained unsuccessful to date. 380 
 381 
Genetic analyses of the Arctic cyanobacterial samples revealed that at least some species within the 382 
communities may have the potential to produce MCs. All of the samples contained at least one gene 383 
of the mcy gene cluster, involved in MC production (Table 1; Supplemental Table 3). The genes 384 
detected, included the mcyA, the mcyB and, in one case, the mcyE region (Table 1, Supplemental 385 
Figure 1), encoding for non-ribosomal peptide synthetases and a hybrid enzyme, respectively [49]. 386 
The signal intensity of mcyA was distinctly higher in sample A which tested positive for MC, 387 
suggesting a high abundance of the MC producer. When compared to the GenBank database 388 
however, some of the sequence similarities to known mcy genes were low (60 to 99 %; Supplemental 389 
Table 3). In general the cyanobacterial mcy operon is known to be highly variable [50,51] with 390 
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sequence similarities of the mcy genes between the two most studied MC producing species, 391 
Microcystis aeruginosa and Planktothrix aghardii, only ranging between 53 and 86 % depending on 392 
the gene region [50]. Low sequence similarities as detected in this study may therefore be a result of 393 
the high geographic and phylogenetic separation between known MC producing cyanobacterial 394 
species from temperate and tropical regions and the Arctic species of this study. More sequence data 395 
and pure cultures are required to confirm genetic variations and phylogenetic relationships.  396 
 397 
4.4 Ecological implications of toxins in Arctic cyanobacterial communities 398 
The concentrations of STX and MC detected (21 µg STX / kg dry weight and 106 µg MC / kg dry 399 
weight, [29]) are low when compared to those found in planktonic cyanobacterial blooms of 400 
temperate and tropical regions (up to 65.6 x 106 µg STX / kg dry weight, [30]; and up to 20 x 106 µg 401 
MC / kg dry weight, [52]) but are comparable to the levels detected in cyanobacterial mats of the 402 
Antarctic (1 to 15,900 µg MC / kg dry weight, [27]). Nevertheless, the presence of these compounds, 403 
albeit in low concentrations, could have a selective long-term effect on the organisms living in and 404 
feeding on the cyanobacterial communities. Depending on the spatial distribution of the toxin 405 
producer and the toxin itself within the mat, as well as on the feeding strategy, microorganisms and 406 
metazoans may be differentially exposed to the toxins. Saxitoxin and MC containing cyanobacteria 407 
have been reported to be toxic to nematodes, crustaceans and rotifers [53–57]; these groups are 408 
also present in many cyanobacterial mats. Trophic interactions in these mat communities are 409 
currently poorly understood and the effects of the toxins on the organisms present are largely 410 
unknown. It has been suggested that rising temperatures could increase toxin concentrations in polar 411 
cyanobacterial communities [29,58] and thus exacerbate potential effects of toxins on metazoan 412 
organisms [54]. In the cryosphere many physiological processes happen just above a minimum 413 
threshold level [59] and energy consuming production of secondary metabolites e.g. MC and STX 414 
may be limited [29]. Kaebernick and Neilan (2001) [19] postulated that MC synthesis is increased 415 
under optimal temperature and growth conditions, which are speculated to be around 20 °C for polar 416 
cyanobacteria [60]. Thus a warmer climate as predicted for the Arctic in current climate change 417 
17 
 
models [61] could elevate the temperature above the minimum threshold level for toxin synthesis, 418 
leading to an increased general metabolic activity and thus an increased level of toxin production 419 
[29,62,63]. Monitoring toxins and changes in cyanobacterial diversity could help in understanding 420 
climate change effects in the polar regions as well as assisting in evaluating the role of cyanobacterial 421 
secondary metabolites in these environments.422 
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 614 
 615 
Figure legends 616 
 617 
Table 1: Genes for toxin production in five Arctic cyanobacterial samples. 618 
Detection of the mcy and sxt operon in five Arctic cyanobacterial communities suggesting the 619 
potential for microcystin and saxitoxin production. 620 
 621 
Table 2: Identification of the microcystin (MC) variant by LC-MS. 622 
Fragment-ion pattern detected for [Asp3, ADMADDA5, Dhb7] MC-RR when observed by electrospray 623 
ionisation collision-induced dissociation. 624 
 625 
Fig 1: Chemical structures of saxitoxin (STX) and microcystin (MC) 626 
General structure of the STXs (A; adapted from Humpage et al. 2008 [8] and the general structure of 627 
the MCs (B; adapted from [64]. 628 
 629 
Fig 2: mRNA expression of the stxA gene. 630 
24 
 
Detection of mRNA expression of the sxtA gene in Arctic cyanobacterial sample A. Two different 631 
primer pairs sxta and sxtA were used resulting in a 650 bp and a 170 bp long product respectively. 632 
Negative controls were performed excluding reverse transcriptase to reduce false positive signals of 633 
DNA contamination. 634 
 635 
Fig 3: Phylogenetic analysis of sxtA. 636 
The 657 bp long sequence obtained is given in boldface; other sequences were obtained from 637 
GenBank. Sequences were aligned and the tree constructed using GeneiousTM software (version 638 
5.5.6) as a Neighbor-Joining tree after the method of Jukes-Cantor. Substitutions per site are given 639 
next to the branches. 640 
 641 
Fig 4: Identification of the microcystin (MC) variant by liquid chromatography – mass spectrometry 642 
(LC-MS). 643 
High pressure LC-MS basepeak chromatograms (m/z 100-2000) of a methanolic extract of Artic 644 
cyanobacterial Sample A (A) and of authentic standards of MC-RR, MC-YR and MC-LR (B) separated 645 
on a C18 column. 646 
 647 
Fig 5: Chemical structure of detected and reference microcystins (MCs). 648 
Structures of MC-RR and [Asp3, ADMADDA5, Dhb7] MC-RR. 649 
